Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia
NCT00006097
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Leukemia
Interventions
DRUG:
CC-1088
Sponsor
Boston Medical Center